1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with an-69 in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (an-69) | Trials (an-69) | Recent Studies (post-2010) (an-69) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 147 | 28 | 9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afentakis, N; Antonopoulou, S; Dinas, C; Iatrou, C; Nomikos, T; Stavropoulos-Giokas, C | 1 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and an-69
| Article | Year |
|---|---|
Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
Topics: Acrylic Resins; Acrylonitrile; Adult; Aged; Cellulose; Complement Activation; Complement C3a; Complement Membrane Attack Complex; Female; Humans; Leukocyte Count; Male; Membranes, Artificial; Middle Aged; Platelet Activating Factor; Platelet Count; Renal Dialysis | 2002 |